ProfileGDS5822 / ILMN_1234503
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 16% 42% 52% 20% 22% 39% 44% 23% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 111.816
GSM1276600PDAC Late Ablation Control 221.142
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 120.352
GSM1276603PDAC Late Ablation 212.120
GSM1276604PDAC Late Ablation 312.922
GSM1303940PDAC Late Ablation_anti-CTLA4 118.339
GSM1303941PDAC Late Ablation_anti-CTLA4 221.444
GSM1303942PDAC Late Ablation_anti-CTLA4 311.623